ESAB Stock Today: February 5 — $1.45B Eddyfi Deal Boosts NDT Reach

The ESAB Eddyfi acquisition is in focus for Canadian investors today. ESAB will buy Quebec City–based Eddyfi Technologies for US$1.45 billion (about C$2 billion) in cash, expanding in non-destructive testing across aerospace, nuclear, and infrastructure. With shares of ESAB supported by improving momentum and an earnings update due March 10, the deal could reshape growth expectations into 2026. Below, we break down terms, financial impact, ESAB stock levels to watch, and what this means for Canada’s advanced inspection ecosystem.

Deal Snapshot and Canadian Impact

ESAB agreed to acquire Eddyfi for US$1.45 billion in cash, funded with cash, debt, and about US$318 million of equity. The parties target a mid‑2026 close, keeping Eddyfi’s headquarters in Quebec City and its leadership in place. ESAB said the move broadens its inspection and monitoring portfolio across high‑growth end markets. Sources: The Globe and Mail and CP24.

The ESAB Eddyfi acquisition strengthens a Canadian hub for non-destructive testing, preserving jobs, R&D, and customer support in Quebec. Eddyfi’s advanced sensors, instruments, and robotics complement ESAB’s global reach, potentially accelerating exports and local supplier activity tied to aerospace, nuclear maintenance, and civil infrastructure renewal. For Canada, it supports a home‑grown technology leader while giving it deeper access to international distribution and scaled production capabilities.

Financial Fit and 2026 Targets

ESAB guides 2026 core revenue of US$2.85–US$2.95 billion. Eddyfi is projected to contribute roughly US$270 million of revenue and about US$80 million of EBITDA in 2026. On these figures, the ESAB Eddyfi acquisition implies near 18x 2026E EBITDA, aligning with premium inspection assets. Execution on cross‑selling and faster hardware‑plus‑software adoption will be key to sustaining margin uplift and cash conversion.

Funding includes cash, new debt, and US$318 million of equity. ESAB enters with interest coverage of about 5.7x and net debt to EBITDA near 2.37x, indicating capacity but limited room for error during integration. Post‑close, investors should watch leverage, interest costs, and free cash flow, especially if rates stay higher. Any deleveraging plan would likely lean on EBITDA growth and disciplined capex.

ESAB Stock Setup for February

Momentum improved ahead of February. Price sits around the 50‑day average at US$114.93 and near the 200‑day at US$118.38. RSI is 64.06, CCI shows overbought at 260.73, and MACD is positive. Bollinger resistance appears near US$118.69, with Keltner upper around US$121.03. A decisive move above US$121 could target the 52‑week high at US$135.84. YTD change stands at 13.33%.

The next earnings announcement is scheduled for March 10, 2026. Street sentiment is constructive: 4 Buys, 0 Holds, 0 Sells. Internal scoring shows a B+ Stock Grade with a BUY suggestion, but valuation (PE near 32x TTM) demands delivery on growth. The ESAB Eddyfi acquisition adds a catalyst; guidance color on NDT orders and software attach will matter.

What Canadian Investors Should Consider

For Canadian holders, the ESAB Eddyfi acquisition deepens exposure to non-destructive testing tied to aerospace supply chains, nuclear life‑extension programs, and infrastructure safety. Keeping Quebec City as HQ should support innovation continuity and customer retention. ESAB’s global sales footprint may accelerate Eddyfi’s exports, while software, sensors, and robotics could lift recurring revenue mix and after‑market pull‑through.

Closing depends on regulatory reviews and integration planning through mid‑2026. Near term, watch leverage, potential share issuance effects, and FX given USD revenue versus CAD costs within Canada. Execution risk includes merging sales channels and product road maps. Any slowdown in aerospace, nuclear maintenance, or public infrastructure budgets could delay expected benefits.

Final Thoughts

Here’s our practical take. The ESAB Eddyfi acquisition secures a Canadian NDT leader under a larger global platform, with Quebec City remaining central. Financially, 2026 targets imply a premium but sensible multiple if ESAB accelerates cross‑selling, boosts software and sensor pull‑through, and protects margins. For traders, the near‑term setup hinges on a break above US$118–US$121 toward US$135. For investors, the March 10 update is the next catalyst: look for order momentum, integration steps, and leverage plans. Canadian investors should track regulatory progress, CAD‑USD dynamics, and any shift in public infrastructure or nuclear timelines. Discipline on cash flow will determine how quickly the deal drives shareholder value.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.